Latest News

Monday, July 25, 2016 | Healthcare Trends

AAIC 2016: Active Treatment of Alzheimer's Disease Reduces Healthcare Costs

New data presented at the ongoing Alzheimer’s Association International Conference (AAIC) 2016 in Toronto suggests that non-treatment of Alzheimer's disease may increase the burden of h…

Read the full story

Tuesday, July 19, 2016 | FDA Approval/Clearance

Ultrasound Treatment for Essential Tremor Wins FDA Approval

The FDA approved Insightec’s Exablate Neuro system, a technology that uses focused ultrasound waves for the non-invasive treatment of essential tremor (ET) in patients who have not responded to …

Read the full story

Tuesday, July 19, 2016 | Business of Medicine, Personnel/Company News

Monteris Medical Appoints Martin J. Emerson President and CEO

Monteris Medical's Board of Directors has appointed Martin J. Emerson as President and Chief Executive Officer effective immediately.  Monteris Medical is a privately hel…

Read the full story

Monday, July 18, 2016 | Personnel/Company News, Product Launches and Updates

Medtronic Updates Spinal Surgery Platform with New Procedures

At the recent International Meeting on Advanced Spine Techniques (IMAST) in Washington, DC, Medtronic launched the Pivox Oblique Lateral Spinal System with Lateral Plate for OLIF25 and Diver…

Read the full story

Monday, July 18, 2016 | Product Launches and Updates

Cefaly Unveils Pocket-Sized, Rechargeable Version of FDA-Approved Migraine Headband

An updated version of Cefaly, the FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraine attacks, is now available in the US. Now three-qu…

Read the full story

Tuesday, June 28, 2016 |

Lilly Convenes Leaders at National Mayor's Conference to Address Impact of Alzheimer's Disease on Local Communities

Eli Lilly and Company expanded its “Community Conversations on Alzheimer's” series with a recent panel discussion at the US Conference of Mayors meeting in Indianapolis, Indiana. Commu…

Read the full story

Tuesday, June 28, 2016 | FDA Approval/Clearance

FDA Grants Priority Review Designation to Genentech’s Investigational RMS and PPMS Agent Ocrevus

The FDA has accepted Genentech’s Biologics License Application (BLA) for Ocrevus (ocrelizumab) for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis …

Read the full story

Tuesday, June 28, 2016 | Phase 3/4 Trials

Investigational Cannabidiol Found Effective as Adjunctive Therapy for Lennox-Gastaut Syndrome

New Phase 3 data suggest that the investigational cannabidiol Epidiolex (cannabidiol, GW Pharmaceuticals) may be an effective adjunctive therapy in the treatment of Lennox-Gastaut syndrome (LGS). In t…

Read the full story

Monday, June 27, 2016 | Business of Medicine, Research and Publications

Analysis Uncovers Health Economic Data for H.P. Acthar® Gel in Dermatomyositis and Polymyositis

Results from two retrospective analyses sponsored by Mallinckrodt plc show that use of the company’s H.P. Acthar® Gel (repository corticotropin injection) offers a cost-effective alternative…

Read the full story

Friday, June 24, 2016 | Personnel/Company News

World Stroke Organization and Medtronic Collaborate to Increase Stroke Awareness

The World Stroke Organization (WSO) is partnering with Medtronic plc to increase stroke awareness through several initiatives. The partnership, unveiled at the 2016 Annual Scientific Session of t…

Read the full story

Wednesday, June 22, 2016 |

Novel SOD1 Pathology Found in Regions of Parkinson’s Disease Brain

While it is already known that superoxide dismutase 1 (SOD1) protein aggregation in the brain is primarily associated with neuronal loss in amyotrophic lateral sclerosis (ALS), new data presented at t…

Read the full story

Tuesday, June 21, 2016 |

New Findings Highlight Racial Disparities in Painful Diabetic Peripheral Neuropathy Diagnosis and Symptoms

New data suggest a need to broaden educational initiatives to promote discussion of painful diabetic peripheral neuropathy (pDPN), particularly among multicultural populations. According to results fr…

Read the full story

Tuesday, June 21, 2016 | FDA Approval/Clearance

FDA Grants Orphan Drug Designation to Investigational Huntington’s Disease Agent

An investigational agent for the treatment of Huntington’s disease (HD) recently received Orphan Drug Designation from the FDA. Developed by WAVE Life Sciences, WVE-120101 is a single Nucleotide…

Read the full story

Tuesday, June 21, 2016 | Personnel/Company News

NPF Updates Enrollment on Parkinson’s Outcomes Project

More than 8,000 individuals have enrolled in the National Parkinson Foundation’s Parkinson's Outcomes Project, the largest-ever clinical study of Parkinson's disease. The study, which is…

Read the full story

Monday, June 13, 2016 | FDA Approval/Clearance

Zecuity Withdrawn from Market Due to Reports of Burning and Scarring

Teva Pharmaceutical Industries has voluntarily suspending marketing and initiated a pharmacy-level recall for Zecuity (sumatriptan iontophoretic transdermal system) patch for migraine headaches in the…

Read the full story
Load More